Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(119 intermediate revisions by 6 users not shown)
Line 3: Line 3:
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''!!'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!Notes
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|PENDING
|
|
|
|
Line 16: Line 22:
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
| ||FQR
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|
|
|
|
Line 29: Line 42:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 36: Line 52:
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|
|
|complete
|
|FQR
|FQR
|PENDING
|8/4/2020 before submission
|
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
| ||FQR
|(trainee), Daynna J.Wolff
|
|
|
|
|pending faculty review
|
|
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|
|FQR
|
|
|-
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|complete
| ||FQR
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 75: Line 110:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|Shashi Shetty
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|complete
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|FQR
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|Disease
|Daynna J. Wolff
|FQR
|PENDING
|
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Daynna J. Wolff
|FQR
|PENDING
|
|
|NON-WHO ENTITY
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|FQR
|Complete
|Complete
|
|
|
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|
|
|Complete
|
|
|FQR
|
|
|NON-WHO ENTITY
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|
|
|Complete
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu+Teresa Smolarek
|    Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|FQR
|PENDING
|
|
|
|
|-
|Complete
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu+Teresa Smolarek
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du+Teresa Smolarek
|    Juvenile Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|FQR
|
|9/1/20
|PENDING
|PENDING
|
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu+Teresa Smolarek
|    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|FQR
|
|PENDING
|
|
|complete
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
| || || ||
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|
|
|complete
|
|
|-
|FQR
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Complete
|
|
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH / MS
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|Complete
|
|
|9/1/20
|pending
|
|
|-
|FQR
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)||JH / MS
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH / MS
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|PENDING
|
|FQR
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH / MS
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|PENDING
|
|
|
|Complete
|
|
|-
|FQR
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH / MS
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH / MS
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)||JH / MS
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|JH / MS
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH / MS
|    Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH / MS
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH / MS
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH / MS
|    Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|Need permission for figure?  Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH / MS
|Complete
|
|
|complete
|
|
|-
|FQR
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
|    Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|9/1/20
|PENDING
|
|
|Add WHO reference
|FQR
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)||JH / MS
| || ||
|Complete
|
|
|
|
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH / MS
|Complete
|
|
| ||
|
|
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)||JH / MS
|Complete
|
|
|Check reference format
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|Complete
|
|
|
|
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH / MS
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH / MS
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH / MS
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH / MS
|Complete
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH / MS
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH / MS
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS
|
|
|-
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH / MS
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|Complete
|
|
|
|
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH / MS
|Complete
|Complete
|02/03/2021||JH / MS
|
|
|
|
|-
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)||JH / MS
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|Complete
|Complete
|
| ||JH / MS
|03/02/2021-MS
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH / MS
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|Complete
|
|
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH / MS
|Complete
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|
|Need permission for figure?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH / MS
|    Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
|Complete
|
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley||JH / MS
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|Complete
|
|
|
|
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)||JH / MS
|Complete
|Complete
|
|
|JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH / MS
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|Complete
|
|
|
|
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)||JH / MS
|Complete
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|Check reference format
|-
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH / MS
|    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH / MS
|    Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty
|Complete
|
|
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)||JH / MS
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|Check reference format
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH / MS
|    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH / MS
|    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|??
|
|
|
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH / MS
|    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|??
|
|
|Complete
| ||JH / MS
|
|Need permission for figure? Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|
|
|-
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|JH / MS
|Complete
|Complete
| ||JH / MS
|
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|JH / MS
|PENDING
|
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|    Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|JH / MS
|PENDING
|
|
|NON-WHO ENTITY
|-
| || || ||
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Add WHO reference
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''|| ||YA
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|YA
|
|PENDING
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
Lisa Smith + Yassmine Akkari
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|Disease
|Helene Bruyere
|YA
|PENDING
|
|
|NON-WHO ENTITY
|-
| || || ||
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|SP
|PENDING
|
|
|
|
|-
|Complete
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
| ||JH / MS
|SP
|PENDING
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|SP
|PENDING
|
|
|
|
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|SP
|Complete
|Complete
| ||JH / MS
|
|
|Malini to review
|Need permission for figure?
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|SP
|
|
|Complete
|Complete
| ||JH / MS
|
|
|
|Malini to review
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|SP
|PENDING
|
|
|Malini to review
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|SP
|PENDING
|
|
|Malini to review
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|SP
|Complete
|Complete
| ||JH / MS
|
|
|
|Malini to review
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|SP
|PENDING
|
|
|
|
|-
|Complete
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
| ||JH / MS
|SP
|PENDING
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|    Mu Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|   Gamma Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Alpha Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|SP
|
|PENDING
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|    Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|SP
|PENDING
|
|
|
|
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|SP
|PENDING
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Zhenya Tang
|    Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|SP
|PENDING
|
|
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|SP
|PENDING
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
|Acute Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|Complete
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|           Primary Amyloidosis||Disease|| ||SP
|Acute Myeloid Leukemia (AML) with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|
|
|PENDING
|
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease|| ||SP
|Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|
|
|PENDING
|
|
|-
|JH / MS
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|
|
|NON-WHO ENTITY
|-
| || ||
|
|
|
|
|-
|         POEMS Syndrome||Disease|| ||SP
|
|
| ||
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease|| ||SP
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||
|SP
|PENDING
|
|
|
|
|-
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|
|
| ||YA
|
|
|
|
|-
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|SP
|PENDING
|
|
|
|
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|SP
|PENDING
|
|
|
|
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|SP
|PENDING
|PENDING
|
|YA
|
|
|
|
|-
|-
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|SP
|PENDING
|
|
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|
|
|Complete
|
|
|-
|YA
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|SP
|PENDING
|
|
|
|
|-
|-
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|SP
|PENDING
|
|
|
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
| || || ||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
|    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|
|
|Complete
|
|
|-
|YA
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
|-
|YA
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|-
|PENDING
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Lymphomatoid Granulomatosis||Disease|| ||GC
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|
|YA
|
|NON-WHO ENTITY
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera||GC
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|Complete
|
|
|
|
|-
|PENDING
|Primary Effusion Lymphoma||Disease|| ||GC
| ||YA
|
|
|
|
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease|| ||GC
| || ||
|
|
|
|
|
|
|-
| ||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|
|
|
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease|| ||GC
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|       Monoclonal B-cell  Lymphocytosis||Disease||
|
|
|
|
|
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|
|-
| || || ||
|
|
|SP
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
|PENDING
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
|Hairy Cell Leukemia||Disease||Snehal Patel
|PENDING
|
|
|
|Complete
|
|
|-
|SP
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
|PENDING
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease|| ||SP
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||SP
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|  Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease|| ||SP
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||SP
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||SP
|
|
|SP
|
|
|
|
|-
|-
|    Severe Mosquito Bite Allergy||Disease|| ||SP
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|
|
|-
|Adult T-cell Leukemia/Lymphoma||Disease|| ||SP
|
|
|SP
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||SP
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
|
|
|
|-
| ||SP
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|SP
|PENDING
|
|
|
|
|-
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|SP
|
|PENDING
|
|
|
|
|-
| ||SP
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|SP
|PENDING
|
|
|
|
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Mu Heavy Chain Disease||Disease||
|SP
|
|PENDING
|
|
|
|
|-
| ||SP
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|SP
|PENDING
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|PENDING
|
|
|
|
|-
|Complete
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||SP
|5/26/2021||SP
|
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease|| ||SP
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
|
|
|
|-
| ||SP
|Sézary Syndrome||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||SP
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|    Lymphomatoid  Papulosis||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease|| ||SP
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||SP
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|
|PENDING
|
|
|-
|SP
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||SP
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|
|
|PENDING
|
|
|-
|SP
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||SP
|
|
|
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|SP
|
|
|
|
|
|
|-
| ||SP
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|SP
|
|
|
|
|
|-
|-
|     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||SP
|           Primary Amyloidosis||Disease||
|
|
|
|
|
|
|-
| ||SP
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|SP
|PENDING
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|SP
|
|PENDING
|
|
|
|
|-
| ||SP
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|SP
|PENDING
|
|
|
|
|-
|-
| || || ||
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||SP
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
|
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
|         POEMS Syndrome||Disease||
|
|
|
|
|
|
|-
| ||SP
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
|         TEMPI Syndrome||Disease||
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease|| ||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease|| ||
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|Lymphomas Associated with HIV Infection||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|
|
|
|
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
Fabiola Quintero-Rivera
|
|
|PENDING
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|          Monomorphic  B-cell PTLD||Disease|| ||
|
|
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|8/15/20
|PENDING
|
|SP
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease|| ||
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
|
|
|SP
|
|
|
|
|-
|-
|   Langerhans Cell  Histiocytosis||Disease|| ||
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|
|
|-
|   Langerhans Cell  Sarcoma||Disease|| ||
|
|
|SP
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease|| ||
| || ||
|
|
|
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
|
|
| ||
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease|| ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|
|
|PENDING
|
|
|-
|Greg Corboy (GC)
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease|| ||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
|
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease|| ||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|-
| || || ||
|
|
|Complete
| ||GC
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Associate Editor'''
!Author Content
(Pending or Complete)
!Editor Reviewed (Date)
!Notes
|-
|-
|BCR
|Primary Effusion Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|ABL1
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RUNX1
|   Multicentric Castleman  Disease||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RUNX1T1
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|MYH11
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|FLT3
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|
|3/11/21
|
|
|
|PENDING
| ||GC
|
|
|
|
|-
|-
|NPM1
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|TP53
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|DNMT3A
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CEBPA
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|IDH1
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|IDH2
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|PML
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|RARA
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|ETV6
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|KIT
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|CBFB
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|GATA2
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|PTEN
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|MLTT3
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|MECOM
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|FGFR1(FLT2)
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|KMT2A
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|DEK
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|NUP214
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|RBM15
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|MKL1
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|DDX41
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|ANKRD26
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|CUX1
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|TET2
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|EZH2
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|FOXP1
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|MYC
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|JAK2
|    Lymphomatoid  Papulosis||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|WT1
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|CBL
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|NF1
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|SUZ12
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|ERG
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|EST2
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|RPS14
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|RB1
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|MPL
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|CHGA
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|CDH1
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|SRSF2
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|DNMT1
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|SP
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|-
|MLTT3
|
|
|
|
|
|
|
|
|-
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|RBM15
|
|
|
|
|
|
|
|
|-
|MKL1
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|-
|ANKRD26
|
|
|
|
|
|
|
|
|-
|CUX1
|
|
|
|
|
|
|
|
|-
|TET2
|
|
|
|
|
|
|
|
|-
|EZH2
|
|
|
|
|
|
|
|
|-
|FOXP1
|
|
|
|
|
|
|
|
|-
|MYC
|
|
|
|
|
|
|
|
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|WT1
|DONE
|
|
|DONE
|
|
|
|
|-
|CBL
|
|
|
|
|
|
|
|
|-
|NF1
|
|
|
|
|
|
|
|
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|ERG
|
|
|
|
|
|
|
|
|-
|EST2
|
|
|
|
|
|
|
|
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|RB1
|
|
|
|
|
|
|
|
|-
|MPL
|
|
|
|
|
|
|
|
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|SRSF2
|
|
|
|
|
|
|
|
|-
|DNMT1
|
|
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
|
|
|
|
|-
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|-
|MN1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
|
|
|
|
|-
|EP300
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
Line 1,731: Line 2,756:
|
|
|-
|-
|ASXL1
|BRCA1
|
|
|
|
|
|-
|MN1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
Line 1,752: Line 2,766:
|
|
|-
|-
|EP300
|BRCA2
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
Line 1,769: Line 2,779:
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,783: Line 2,789:
|
|
|
|
|
|
|
|-
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"